The latest price target for Xtant Medical Hldgs (AMEX:XTNT) was reported by BTIG on May 16, 2024. The analyst firm set a price target for $3.00 expecting XTNT to rise to within 12 months (a possible 289.61% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Xtant Medical Hldgs (AMEX:XTNT) was provided by BTIG, and Xtant Medical Hldgs maintained their buy rating.

There is no last upgrade for Xtant Medical Hldgs

There is no last downgrade for Xtant Medical Hldgs.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xtant Medical Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xtant Medical Hldgs was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.

While ratings are subjective and will change, the latest Xtant Medical Hldgs (XTNT) rating was a maintained with a price target of $2.00 to $3.00. The current price Xtant Medical Hldgs (XTNT) is trading at is $0.77, which is out of the analyst’s predicted range.